Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China.
Aging (Albany NY). 2020 Jun 16;12(12):11990-12001. doi: 10.18632/aging.103365.
This study aims to demonstrate the impact of the cumulative burden of low density lipoprotein-cholesterol (cumLDL-c) and high sensitivity C-reactive protein (cumhs-CRP) on cardiovascular risk.
During the 4.62 (±0.70) years of follow-up, 2,148 (5.92%) participants had MACE. Both of cumLDL-c and cumhs-CRP were independent risk factors for MACE. In participants without cumLDL-c during 2006-2013, the participants with cumhs-CRP had higher MACE risk during the subsequent 5 years, than those without cumhs-CRP (hazard ratio [HR]: 1.24, 95% confidence interval [CI]:1.04-1.47). In addition, cumhs-CRP correlated with MACE in a cumhs-CRP level-dependent pattern.
This study validated the effects of residual inflammation risk in patients with low LDL-c Level in a general population, using long-term burdens of hs-CRP or LDL-c other than a single time-point level.
The Kailuan study is a prospective, population-based study began in 2006. These total 36,421 participants completed 4 measurements of hs-CRP and LDL-c biennially from 2006-2013. Cumhs-CRP or cumLDL-c levels were calculated as the number of interval years multiplied by the Δhs-CRP (more than 2.0 mg/L) or ΔLDL-c (more than 2.6 mmol/L). Outcomes measured during follow-up (2012-2017) were defined as major adverse cardiac events (MACE), including ischemic stroke, myocardial infarction, and all-cause mortality.
本研究旨在探讨低密度脂蛋白胆固醇(cumLDL-c)和高敏 C 反应蛋白(cumhs-CRP)累积负担对心血管风险的影响。
在 4.62(±0.70)年的随访期间,2148(5.92%)名参与者发生了主要不良心血管事件(MACE)。cumLDL-c 和 cumhs-CRP 均是 MACE 的独立危险因素。在 2006-2013 年期间没有 cumLDL-c 的参与者中,在随后的 5 年内,cumhs-CRP 升高的参与者发生 MACE 的风险高于 cumhs-CRP 正常的参与者(危险比 [HR]:1.24,95%置信区间 [CI]:1.04-1.47)。此外,cumhs-CRP 与 MACE 之间存在依赖于 cumhs-CRP 水平的相关性。
本研究使用除单次时间点水平之外的 hs-CRP 或 LDL-c 的长期负担,验证了在 LDL-c 水平较低的患者中残留炎症风险的作用。
开滦研究是一项始于 2006 年的前瞻性、基于人群的研究。这些总共 36421 名参与者在 2006-2013 年期间每两年进行 4 次 hs-CRP 和 LDL-c 测量。cumhs-CRP 或 cumLDL-c 水平计算为间隔年数乘以 Δhs-CRP(超过 2.0mg/L)或 ΔLDL-c(超过 2.6mmol/L)。在随访期间(2012-2017 年)测量的结局定义为主要不良心脏事件(MACE),包括缺血性卒中和心肌梗死以及全因死亡率。